Cargando…

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient

Autoimmune liver disease management goals are primarily slowing disease progression and symptomatic treatment. There are few options for curative medical management other than transplant for a spectrum of autoimmune liver disease that encompasses autoimmune hepatitis, primary biliary cirrhosis, prim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abhyankar, Anita, Tapper, Elliot, Bonder, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915192/ https://www.ncbi.nlm.nih.gov/pubmed/24380894 http://dx.doi.org/10.3390/ph7010018

Ejemplares similares

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Adherence to immunosuppressive therapy following liver transplantation: an integrative review
por: Oliveira, Ramon Antônio, et al.
Publicado: (2016)

Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis
por: Papasavvas, Ioannis, et al.
Publicado: (2022)

Liver transplant immunosuppression during the COVID-19 pandemic()
por: Forns, Xavier, et al.
Publicado: (2020)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

A Comprehensive Review of Immunosuppression Used for Liver Transplantation
por: Mukherjee, Sandeep, et al.
Publicado: (2009)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Immunosuppressive Therapy for Chronic Liver Disease
por: Murray-Lyon, I. M., et al.
Publicado: (1973)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
por: Albekairy, Abdulkareem M., et al.
Publicado: (2018)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
por: Liu, Fu-Chao, et al.
Publicado: (2017)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression
por: Reyes, Amanda, et al.
Publicado: (2022)

Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis
por: Freedman, Benjamin L., et al.
Publicado: (2020)

Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation
por: Dirks, Meike, et al.
Publicado: (2021)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Diffusion MRI Findings in Encephalopathy Induced by Immunosuppressive Therapy after Liver Transplantation
por: Tinelli, Emanuele, et al.
Publicado: (2020)

Immune-Mediated Therapies for Liver Cancer
por: Aravalli, Rajagopal N., et al.
Publicado: (2017)

Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
por: van Laar, Jacob M
Publicado: (2000)

Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023)

New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy
por: Chaitou, Ali R, et al.
Publicado: (2022)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Phospho-specific flow cytometry for pharmacodynamic monitoring of immunosuppressive therapy in transplantation
por: Baan, Carla, et al.
Publicado: (2012)

Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis
por: Ferrigno, Bryan, et al.
Publicado: (2022)

Individualizing immunosuppression in lung transplantation
por: McDermott, Jennifer K., et al.
Publicado: (2018)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Zaydfudim, Victor M., et al.
Publicado: (2016)

Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease
por: Suri, Jaspreet S., et al.
Publicado: (2020)

New immunosuppressive drugs in heart transplantation
por: Costanzo, Maria Rosa
Publicado: (2001)

New immunosuppressive agents in pediatric transplantation
por: Nguyen, Christina, et al.
Publicado: (2014)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0spqm1gdgmkdlkg8u4m10a8g27